| Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey B Yurttas, BC Poyraz, N Sut, A Ozdede, M Oztas, S Uğurlu, F Tabak, ... Rheumatology international 41, 1105-1114, 2021 | 140 | 2021 |
| Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly E Seyahi, G Bakhdiyarli, M Oztas, MA Kuskucu, Y Tok, N Sut, G Ozcifci, ... Rheumatology international 41 (8), 1429-1440, 2021 | 85 | 2021 |
| Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients B Yurttaş, M Oztas, A Tunc, İİ Balkan, OF Tabak, V Hamuryudan, E Seyahi Internal and Emergency Medicine 15, 1567-1571, 2020 | 32 | 2020 |
| Atorvastatin-induced dermatomyositis M Oztas, S Ugurlu, O Aydin Rheumatology International 37, 1217-1219, 2017 | 21 | 2017 |
| The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome G Ozcifci, T Aydin, Z Atli, II Balkan, F Tabak, M Oztas, Y Ozguler, S Ugurlu, ... Rheumatology International 42 (1), 101-113, 2022 | 15 | 2022 |
| Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine M Oztas, M Bektas, I Karacan, N Aliyeva, A Dag, S Aghamuradov, ... Journal of medical virology 94 (7), 3431-3437, 2022 | 6 | 2022 |
| Efficacy and safety of imatinib treatment in elderly patients with chronic myeloid leukemia: real-life data and a single-center experience AE Eşkazan, D Özmen, M Öztaş, F Bektaş, EA Bayraktar, S Sadri, ... Clinical Lymphoma Myeloma and Leukemia 21 (8), 549-557, 2021 | 6 | 2021 |
| Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors S Ugurlu, R Akcin, AY Ayla, B Kocazeybek, M Oztas, G Can, ... Rheumatology 61 (SI2), SI194-SI196, 2022 | 5 | 2022 |
| Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center M Öztaş, H Özgül, E Seyahi, S Uğurlu Turkish journal of medical sciences 52 (4), 917-925, 2022 | 4 | 2022 |
| Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case report E Cerme, M Oztas, II Balkan, EA Cetin, S Ugurlu Modern Rheumatology Case Reports 6 (1), 140-144, 2022 | 1 | 2022 |
| A Rare Cause of AA Amyloidosis: Idiopathic Retroperitoneal Fibrosis S Ugurlu, BH Egeli, S Aslan, M Oztas, M Melikoglu JCR: Journal of Clinical Rheumatology 27 (8S), S685, 2021 | 1 | 2021 |
| Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia M Öztaş, I Muradov, A Erçalışkan, AS Demiröz, Ş Batur, AE Eşkazan, ... Turkish Journal of Hematology 38 (3), 226, 2021 | 1 | 2021 |
| Dijital ülser nedeniyle bosentan kullanan sistemik sklerozis hastalarında tedavide kalım süresi ve yan etki profilinin değerlendirilmesi: gerçek yaşam deneyimi M Öztaş, H Özgül, S Uğurlu RAED Journal/RAED Dergisi 12 (2), 2020 | 1 | 2020 |
| Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience M Oztas, I Altun, AY Ayla, E Cerme, C Demirdag, S Asa, K Sonmezoglu, ... International Journal of Rheumatic Diseases 26 (9), 1714-1721, 2023 | | 2023 |
| AB1602 CROSS COUNTRY DIFFERENCES IN B/TSDMARD PRESCRIPTION BEHAVIOR: ASSOCIATIONS BETWEEN SOCIOECONOMICS, REAL WORLD B/TSDMARD USE AND DISEASE OUTCOMES I Nevins, D Courvoisier, A Finckh, R Fritsch-Stork, D Nordström, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 2035-2036, 2023 | | 2023 |
| Lupus Nefritinde Yakın Gelecekteki Tedaviler M ÖZTAŞ, S UĞURLU Turkiye Klinikleri Rheumatology-Special Topics 16 (3), 97-100, 2023 | | 2023 |
| AB1082 FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE M Oztas, M Bektaş, I Karacan, N Aliyeva, A Dag, S Aghamuradov, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1660-1661, 2022 | | 2022 |
| AB1502 AWARENESS OF BIOLOGICAL AGENTS RELATED SIDE EFFECTS AMONG INTERNAL MEDICINE RESIDENTS IN A UNIVERSITY HOSPITAL M Oztas, S Ugurlu Annals of the Rheumatic Diseases 81 (Suppl 1), 1854-1854, 2022 | | 2022 |
| AB1470 DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF PATIENTS WITH FMF? M Oztas, O Selvi, B Ergezen, H Ozdogan, S Ugurlu Annals of the Rheumatic Diseases 81 (Suppl 1), 1840-1841, 2022 | | 2022 |
| Concerns Regarding the Analysis of a Takayasu Arteritis Cohort: Comment on the Article by Goel et al. H Yazici, M Oztas, Y Yazici Arthritis & Rheumatology (Hoboken, NJ) 73 (10), 1948-1948, 2021 | | 2021 |
